Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Micron Technology, Inc. (MU) vs Zoetis Inc (ZTS) Price & Performance

Micron Technology, Inc.Trade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Micron Technology, Inc. vs Zoetis Inc — how do they compare? Micron Technology, Inc. trades at $1,029 (market cap $1.17T), while Zoetis Inc trades at $74.76 (market cap $30.20B). The key difference: Micron Technology, Inc. is far larger — about 38.7× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold Micron Technology, Inc. for 48 Days and Zoetis Inc for 70 Days on average.

MUZTS
Market Cap
$1.17T$30.20B
Volume
29,425,9066,175,327
Sector
TechnologyHealth
52-Week High
$1.21K$147.53
52-Week Low
$181.60$69.09
Typical Hold Time
48 Days70 Days
Enterprise Value
$1.13T$37.76B
Dividend Yield
0.06%2.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Micron Technology, Inc.

Micron Technology (MU) trades at $1,029, down 5.42% over the past session, despite strong fundamental performance. The stock shows bullish technical signals with robust earnings beats in recent quarters (Q2 2026 EPS of $33.42 vs. $31.77 expected) and exceptional profitability metrics, including a 63.8% net income margin. Recent news highlights multi-year growth driven by AI memory demand and strategic customer agreements covering 35% of revenue through 2030.

Outlook remains positive with analyst consensus strongly bullish (82.85% buy ratings) and a $1,590 price target, though risks include cyclical memory pricing and potential AI demand normalization. The company's strong cash flow generation ($17.53B operating cash flow in 2025) and expanding margins support continued upside potential for long-term investors.

Zoetis Inc

Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.

Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MU
75% Buy25% Sell
Avg holding period · 48 Days
ZTS

No sentiment data available yet.

Top news

Latest headlines on both assets

About Micron Technology, Inc.

Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.

Read more on MU →

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS →